Mineral bone disease (MBD) is a common complication of chronic kidney disease (CKD)
characterized by disruption of normal mineral homeostasis within the body. One or more of …

Patients with chronic kidney disease (CKD) have a predisposition to develop vascular
calcification due to dysregulated homeostatic mechanisms, which lead to an imbalance in …

The Kidney Disease: Improving Global Outcomes (KDIGO) 2017 Clinical Practice Guideline
Update for the Diagnosis, Evaluation, Prevention, and Treatment of chronic kidney disease …

Vitamin D is a fat-soluble hormone that has endocrine, paracrine and autocrine functions.
Consumption of vitamin D-supplemented food & drugs have increased significantly in the …

Uremic toxins can induce endothelial dysfunction in patients with chronic kidney disease
(CKD). Indeed, the structure of the endothelial monolayer is damaged in CKD, and studies …

Patients with chronic kidney disease (CKD) have an elevated prevalence of atheromatous
(ATH) and/or non-atheromatous (non-ATH) cardiovascular disease (CVD) due to an array of …

In patients with advanced chronic kidney disease (CKD), the accumulation of uremic toxins,
caused by a combination of decreased excretion secondary to reduced kidney function and …

Concerns for agri-food safety and environmental management require development of
simple to use and cost-and time-effective multiplex sensors for point-of-need (PON) …

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and
Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) - PMC Back to …

It is increasingly acknowledged that mineral and bone disorders (MBDs) contribute to the
excessively high cardiovascular (CV) disease morbidity and mortality observed in patients …